MAPT and Alzheimer disease: In studying individuals with DS and AD (DS–AD), Condello and collaborators found a significant difference in prion activity, compared to other forms of AD, with DS brains showing a continuously increasing prion activity of Tau and amyloid with age; this is contrary to the reduced prion activity of these proteins that is observed in the brains of patients with LOAD or EOAD [18].